vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Unusual Machines, Inc. (UMAC). Click either name above to swap in a different company.

Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $4.9M, roughly 1.9× Unusual Machines, Inc.). Unusual Machines, Inc. runs the higher net margin — -215.7% vs -234.3%, a 18.6% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 144.4%). Over the past eight quarters, Unusual Machines, Inc.'s revenue compounded faster (181.3% CAGR vs 35.3%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

Thinking Machines Lab Inc. is an American artificial intelligence (AI) startup founded by Mira Murati, the former chief technology officer of OpenAI. The company was founded in February 2025, and by July had completed an early-stage funding round led by Andreessen Horowitz, raising $2 billion at a valuation of $12 billion overall from investors such as Nvidia, AMD, Cisco, and Jane Street. The company is based in San Francisco and structured as a public benefit corporation.

FHTX vs UMAC — Head-to-Head

Bigger by revenue
FHTX
FHTX
1.9× larger
FHTX
$9.2M
$4.9M
UMAC
Growing faster (revenue YoY)
FHTX
FHTX
+79.3% gap
FHTX
223.8%
144.4%
UMAC
Higher net margin
UMAC
UMAC
18.6% more per $
UMAC
-215.7%
-234.3%
FHTX
Faster 2-yr revenue CAGR
UMAC
UMAC
Annualised
UMAC
181.3%
35.3%
FHTX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FHTX
FHTX
UMAC
UMAC
Revenue
$9.2M
$4.9M
Net Profit
$-21.7M
$-10.6M
Gross Margin
36.2%
Operating Margin
-258.2%
-198.7%
Net Margin
-234.3%
-215.7%
Revenue YoY
223.8%
144.4%
Net Profit YoY
-11.1%
61.0%
EPS (diluted)
$-0.35
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
UMAC
UMAC
Q4 25
$9.2M
$4.9M
Q3 25
$8.2M
$2.1M
Q2 25
$7.6M
$2.1M
Q1 25
$6.0M
$2.0M
Q4 24
$2.9M
$2.0M
Q3 24
$7.8M
$1.5M
Q2 24
$6.9M
$1.4M
Q1 24
$5.0M
$618.9K
Net Profit
FHTX
FHTX
UMAC
UMAC
Q4 25
$-21.7M
$-10.6M
Q3 25
$-15.8M
$1.6M
Q2 25
$-17.9M
$-7.0M
Q1 25
$-18.8M
$-3.3M
Q4 24
$-19.5M
$-27.1M
Q3 24
$-19.1M
$-2.1M
Q2 24
$-23.0M
$-1.6M
Q1 24
$-25.0M
$-1.1M
Gross Margin
FHTX
FHTX
UMAC
UMAC
Q4 25
36.2%
Q3 25
39.4%
Q2 25
37.4%
Q1 25
24.3%
Q4 24
27.7%
Q3 24
26.1%
Q2 24
27.5%
Q1 24
33.0%
Operating Margin
FHTX
FHTX
UMAC
UMAC
Q4 25
-258.2%
-198.7%
Q3 25
-226.9%
-232.4%
Q2 25
-279.2%
-338.5%
Q1 25
-385.0%
-160.0%
Q4 24
-840.5%
-642.3%
Q3 24
-305.5%
-95.4%
Q2 24
-386.6%
-111.4%
Q1 24
-558.3%
-175.5%
Net Margin
FHTX
FHTX
UMAC
UMAC
Q4 25
-234.3%
-215.7%
Q3 25
-194.4%
75.1%
Q2 25
-237.3%
-327.9%
Q1 25
-316.4%
-159.9%
Q4 24
-682.9%
-1353.2%
Q3 24
-244.9%
-140.0%
Q2 24
-333.6%
-114.3%
Q1 24
-495.4%
-178.7%
EPS (diluted)
FHTX
FHTX
UMAC
UMAC
Q4 25
$-0.35
$-0.26
Q3 25
$-0.25
$0.05
Q2 25
$-0.28
$-0.32
Q1 25
$-0.30
$-0.21
Q4 24
$-0.23
$-3.20
Q3 24
$-0.31
$-0.30
Q2 24
$-0.45
$-0.16
Q1 24
$-0.59
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
UMAC
UMAC
Cash + ST InvestmentsLiquidity on hand
$80.9M
$142.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-108.5M
$174.9M
Total Assets
$198.1M
$182.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
UMAC
UMAC
Q4 25
$80.9M
$142.5M
Q3 25
$89.3M
$81.1M
Q2 25
$72.6M
$38.9M
Q1 25
$61.0M
$5.0M
Q4 24
$55.5M
$3.8M
Q3 24
$57.7M
$1.7M
Q2 24
$138.9M
$2.2M
Q1 24
$79.3M
$3.2M
Stockholders' Equity
FHTX
FHTX
UMAC
UMAC
Q4 25
$-108.5M
$174.9M
Q3 25
$-89.7M
$106.0M
Q2 25
$-76.7M
$51.3M
Q1 25
$-61.7M
$15.9M
Q4 24
$-45.5M
$14.8M
Q3 24
$-28.3M
$19.2M
Q2 24
$-14.3M
$20.0M
Q1 24
$-97.5M
$21.2M
Total Assets
FHTX
FHTX
UMAC
UMAC
Q4 25
$198.1M
$182.7M
Q3 25
$205.0M
$113.1M
Q2 25
$226.2M
$52.4M
Q1 25
$258.7M
$17.3M
Q4 24
$284.0M
$16.1M
Q3 24
$308.4M
$24.5M
Q2 24
$328.6M
$25.2M
Q1 24
$255.0M
$24.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
UMAC
UMAC
Operating Cash FlowLast quarter
$-22.3M
$-9.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
UMAC
UMAC
Q4 25
$-22.3M
$-9.8M
Q3 25
$-18.9M
$-7.5M
Q2 25
$-21.0M
$-2.7M
Q1 25
$-24.0M
$-1.2M
Q4 24
$-24.5M
$-1.3M
Q3 24
$-21.0M
$-536.7K
Q2 24
$-25.5M
$-986.2K
Q1 24
$-29.3M
$-1.2M
Free Cash Flow
FHTX
FHTX
UMAC
UMAC
Q4 25
Q3 25
$-8.8M
Q2 25
$-21.0M
Q1 25
$-24.0M
Q4 24
$-25.0M
Q3 24
$-21.3M
Q2 24
$-25.6M
Q1 24
$-29.4M
FCF Margin
FHTX
FHTX
UMAC
UMAC
Q4 25
Q3 25
-413.2%
Q2 25
-278.2%
Q1 25
-403.2%
Q4 24
-875.3%
Q3 24
-273.0%
Q2 24
-371.0%
Q1 24
-583.1%
Capex Intensity
FHTX
FHTX
UMAC
UMAC
Q4 25
0.0%
Q3 25
0.0%
60.3%
Q2 25
0.3%
Q1 25
0.5%
Q4 24
16.8%
Q3 24
4.0%
0.0%
Q2 24
0.2%
Q1 24
2.0%
Cash Conversion
FHTX
FHTX
UMAC
UMAC
Q4 25
Q3 25
-4.70×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FHTX
FHTX

Segment breakdown not available.

UMAC
UMAC

Retail Revenue$4.5M92%
Other$412.7K8%

Related Comparisons